Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C2B | O00750 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
| ▸ | DCTPP1 | Q9H773 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 4/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.39 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6488276 | 0.90 | PIK3C2B (0.50) | PIK3C2BPLA2G2ACCR2DCTPP1MCL1 | |
| SCHEMBL6499832 | 0.88 | PLA2G2A (0.42) | PLA2G2ALMNAMAPTHTTDCTPP1 | |
| SCHEMBL6488906 | 0.86 | MEN1 (0.40) | PLA2G2ASMN1; SMN2LMNAGAAMAPT | |
| SCHEMBL6489154 | 0.85 | ALDH1A1 (0.47) | PLA2G2ASMN1; SMN2LMNAGAAMAPT | |
| SCHEMBL6502915 | 0.84 | SMN1; SMN2 (0.44) | PLA2G2ASMN1; SMN2LMNAMAPTHTT | |
| SCHEMBL6488241 | 0.84 | MCL1 (0.43) | PLA2G2AMAPTHTTDCTPP1MCL1 | |
| SCHEMBL6501772 | 0.84 | PIK3C2B (0.47) | PIK3C2BPLA2G2AGAAMAPTHTT | |
| SCHEMBL6491512 | 0.83 | MCL1 (0.41) | PLA2G2ALMNAMAPTDCTPP1MCL1 | |
| SCHEMBL6488675 | 0.83 | PLA2G2A (0.41) | PLA2G2ASMN1; SMN2LMNAGAAMAPT | |
| SCHEMBL6502360 | 0.83 | PABPC1 (0.39) | PLA2G2AGAAMCL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| WO-2004108686-A2 | BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | PIK3C2B 2433/4885PLA2G2A 4801/4885SMN1; SMN2 1128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.